Danaher Corporation $DHR Stake Boosted by Union Bancaire Privee UBP SA

Union Bancaire Privee UBP SA increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 116.7% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 142,263 shares of the conglomerate’s stock after purchasing an additional 76,601 shares during the quarter. Union Bancaire Privee UBP SA’s holdings in Danaher were worth $25,078,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. Beaumont Asset Management L.L.C. grew its position in Danaher by 15.7% in the first quarter. Beaumont Asset Management L.L.C. now owns 3,240 shares of the conglomerate’s stock valued at $614,000 after acquiring an additional 440 shares during the period. Cambient Family Office LLC increased its position in shares of Danaher by 2.5% during the 1st quarter. Cambient Family Office LLC now owns 17,929 shares of the conglomerate’s stock worth $3,407,000 after purchasing an additional 434 shares in the last quarter. Value Partners Investments Inc. increased its position in shares of Danaher by 17.3% during the 1st quarter. Value Partners Investments Inc. now owns 7,522 shares of the conglomerate’s stock worth $1,426,000 after purchasing an additional 1,110 shares in the last quarter. River Street Advisors LLC lifted its holdings in Danaher by 11.5% during the 1st quarter. River Street Advisors LLC now owns 3,733 shares of the conglomerate’s stock valued at $708,000 after purchasing an additional 385 shares during the last quarter. Finally, Venturi Wealth Management LLC boosted its position in Danaher by 14.5% in the first quarter. Venturi Wealth Management LLC now owns 85,008 shares of the conglomerate’s stock valued at $16,117,000 after buying an additional 10,788 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

DHR opened at $195.67 on Friday. The stock has a market cap of $138.49 billion, a P/E ratio of 37.85, a P/E/G ratio of 2.46 and a beta of 0.81. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company has a fifty day simple moving average of $178.81 and a 200 day simple moving average of $201.69.

Danaher (NYSE:DHR) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same period last year, the company posted $1.88 EPS. The business’s quarterly revenue was up 3.7% on a year-over-year basis. On average, research analysts expect that Danaher Corporation will post 8.44 EPS for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on DHR. Wolfe Research cut shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. UBS Group decreased their price target on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Argus cut their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a report on Friday, March 27th. Finally, Evercore lifted their price target on Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a report on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.